This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA
Book Now
Menu
Book

Kevin Seibert, PhD
Vice President, Engineering, Synthetic Molecule Design and Development at Eli Lilly and Company
Speaker

Agenda Sessions

  • Chemically Convergent Peptide Synthesis: Eliminating SPPS and the Impact on Registered Starting Material Designations

    , 8:30am
    View Session

At this event

Prev
Next
Laura Sepp-Lorenzino, PhD
Biotech Executive, Board Member and Industry Advisor
GNMmeds LLC

See Kevin at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now